2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Jens D Lundgren, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase IV Vaccine Study Under the National Cohort Study of Effectiveness and Safety of SARS-CoV-2 (COVID-19) Vaccines. Johnson & Johnson - SARS CoV 2 Infection | Phase 4 | Completed | Jens D Lundgren, MD | 25 | 2021-07-05 | 2024-04-11 |
| National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE) COMIRNATY - BioNTech Manufacturing GmbH, COVID-19 Vaccine Moderna dispersion for injection - MODERNA BIOTECH, COVID-19 Vaccine AstraZeneca suspension for injection - SARS-CoV Infection | Phase 4 | Completed | Jens D Lundgren, MD | 7600 | 2021-02-08 | 2024-04-12 |
COVID-19 (2) · Severe Acute Respiratory Syndrome (1)
Ad26COVS1 (1) · Injections (1)
Denmark (2)